Шифр: CS7/2009/23/1    Журнал Cardiovascular Drugs and Therapy [Електронний ресурс]. - Amsterdam : Springer Netherlands. - ISSN 15737241. - Виходит раз на два місяця 2009р. Vol. 23 N 1 Зміст: Raitt, M. H. Are n -3 Polyunsaturated Fatty Acids Antiarrhythmic in the Absence of Ischemia? / M. H. Raitt. - P.1-3 The Role of n-3 PUFAs in Preventing the Arrhythmic Risk in Patients with Idiopathic Dilated Cardiomyopathy. - P.5-15 Інші автори: Nodari S., Metra M., Milesi G., Manerba A., Cesana B. M., Gheorghiade M., Dei C. L. Selective PKC Beta Inhibition with Ruboxistaurin and Endothelial Function in Type-2 Diabetes Mellitus. - P.17-24 Інші автори: Mehta N. N., Sheetz M., Price K., Comiskey L., Amrutia S., Iqbal N., Mohler E. R., Reilly M. P. Horowitz, J. Clinical Trials Update from the European Society of Cardiology Congress in Munich, 2008: TIME-CHF, CARESS-in-AMI, TRITON-TIMI 38, EUROPA, AF-CHF, and ADVANCE / J. Horowitz, W. J. Remme, C. Torp-Pedersen. - P.25-29 Shah, P. K. Inflammation and Plaque Vulnerability / P. K. Shah. - P.31-40 Magnus, B. Leukotriene Signaling in Atherosclerosis and Ischemia / B. Magnus. - P.41-48 Burke, J. E. Phospholipase A2 Biochemistry / J. E. Burke, E. A. Dennis. - P.49-59 Boyanovsky, B. B. Biology of Secretory Phospholipase A2 / B. B. Boyanovsky, N. R. Webb. - P.61-72 Stafforini, D. M. Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2) / D. M. Stafforini. - P.73-83 Koenig, W. Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence / W. Koenig, N. Khuseyinova. - P.85-92 Rosenson, R. S. Future Role for Selective Phospholipase A2 Inhibitors in the Prevention of Atherosclerotic Cardiovascular Disease / R. S. Rosenson. - P.93-101 Є примірники у відділах: всього 1 : ВКТ (1) Вільні: ВКТ (1)